Long-term studies demonstrate sustained improvements in physical capacity and metabolic function following senescent cell clearance, suggesting FOXO4-DRI treatment can fundamentally alter aging trajectories
In proof-of-concept studies, NNMT inhibitors (NNMTis) have demonstrated promise as potential treatments for obesity and obesity-related metabolic comorbidities (e.g., T2D, fatty liver) 8,9,13
Carefully sourced treatment options selected through licensed medical channels not research-grade products
Everybody responds differently and discussing all factors with your surgeon before the day of the surgery is highly recommended
Direct intravenous NAD+ is tested at doses of 500 to 1000 mg infused over 2 to 6 hours
Across technical and preclinical contexts, these peptides are referenced strictly for educational and research purposes, with emphasis on analytical handling, standardized protocols, and pathway-focused investigation under appropriately controlled laboratory conditions